相关实验视频

Updated: Sep 18, 2025

Exploring m6A and m5C Epitranscriptomes upon Viral Infection: an Example with HIV

Exploring m6A and m5C Epitranscriptomes upon Viral Infection: an Example with HIV

Published on: March 5, 2022

向细胞内mRNAm6A-修饰剂,用于推进免疫疗法

Sunil Kumar¹, Mithun Sinha¹

¹Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.

Journal of advanced research

|June 25, 2025

概括

探索RNA修饰,特别是m6A,为增强癌症免疫治疗提供了新的途径. 这次审查强调了m6A修饰剂作为潜在的治疗点,以改善抗PD1抗体的疗效和个性化药物策略.

科学领域:

经转录学和癌症免疫疗法
RNA修饰酶 (写字器,擦拭器,阅读器) 的使用
N6-甲基氨酸 (m6A) 的修改

背景情况:

免疫疗法,特别是抗PD1抗体,在癌症治疗中显示出临床成功,但在许多患者中面临有限的反应率.
针对DNA和基因组的表观遗传药物已经建立,但针对mRNA修饰机械的药物正在出现.
发现RNA修饰酶为克服当前制药药物的局限性提供了一种新的方法.

研究的目的:

审查m6A修饰剂在开发新型癌症免疫疗法的治疗潜力.
探索增强个性化疗法的策略,通过将m6A修饰剂与CISH等细胞内检查点基因共同向.
提出一种双重治疗方法,将m6A修饰剂与抗PD1抗体结合起来,以提高治疗效率.

主要方法:

关于m6A修饰及其在细胞和免疫功能中的作用的科学文献的审查.
分析m6A修饰剂在向特定免疫细胞子集方面的潜力.
确定参与开发基于m6A的RNA修饰药物 (RMD) 的生物制药公司和临床试验.

主要成果:

m6A修饰是调节生物过程和免疫反应的关键表皮转录机制.
m6A-修饰剂在免疫细胞内发现新型治疗点方面具有前景.
与其他基因共同向m6A修饰剂或将其与抗PD1抗体结合,可能会提高治疗结果.

结论:

使用m6A-修饰剂为开发下一代癌症免疫疗法提供了一个有希望的前沿.
个性化治疗可以通过免疫细胞工程和涉及m6A-修饰剂的共同向策略来推进.
对基于m6A的RNA修饰药物的进一步研究对于改善向癌症治疗至关重要.

关键词:

癌症免疫疗法癌症免疫疗法史诗转录组学史诗转录组学细胞内免疫检查点细胞内免疫检查点修改RNA的药物是一种修改RNA的药物.m(6) 甲基化-甲基化

更多相关视频

In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells

In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells

Published on: November 13, 2014

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Regulation of Expression at Multiple Steps

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...